メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
外科学(消化器・腫瘍・総合外科)講座
富山大学
医学系
概要
フィンガープリント
ネットワーク
プロファイル
(13)
プロジェクト
(14)
研究成果
(322)
データセット
(6)
フィンガープリント
外科学(消化器・腫瘍・総合外科)講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Pancreas Cancer
100%
Neoplasm
86%
Surgery
82%
Hepatocellular Carcinoma
63%
Abdominal Cancer
54%
Hepatectomy
53%
Pancreaticoduodenectomy
50%
Recurrent Disease
50%
Malignant Neoplasm
39%
Overall Survival
37%
Pancreas Adenocarcinoma
32%
Prognostic Factor
30%
Metastatic Carcinoma
27%
Chemotherapy
26%
Hepatic Portal Vein
24%
Pancreas Fistula
23%
Pancreatectomy
23%
Distal Pancreatectomy
23%
Multivariate Analysis
22%
Esophagectomy
21%
Esophageal Squamous Cell Carcinoma
21%
Liver Metastasis
20%
Lymph Node Metastasis
20%
Gastrectomy
19%
Computer Assisted Tomography
18%
Messenger RNA
18%
Cancer Cell
17%
Esophagus
16%
Intraductal Papillary Mucinous Tumor
15%
Gemcitabine
15%
Adjuvant Chemotherapy
15%
Lymphocyte
15%
Bleeding
15%
Peritoneum Metastasis
14%
Cancer
14%
Cholangiocarcinoma
13%
Disease
13%
Postoperative Complication
13%
Adenocarcinoma
13%
Recurrence Free Survival
13%
Esophageal Cancer
12%
Disease Free Survival
12%
Lymph Node
12%
Biological Marker
11%
Colorectal Carcinoma
11%
Hazard Ratio
11%
Survival Rate
11%
Surgical Anastomosis
11%
Tail
11%
Pancreatic Surgery
11%
Carcinoma
10%
Retroperitoneal Lymph Node Dissection
10%
Odds Ratio
10%
Paclitaxel
9%
Chemoradiotherapy
9%
Artery
9%
Cytotechnology
9%
Ulcerative Colitis
8%
Splenic Vein
8%
Predictive Factor
8%
Platelet
8%
Skeletal Muscle
8%
Univariate Analysis
8%
Nutrition Assessment
7%
Melanoma Antigen
7%
Fluorodeoxyglucose
7%
Randomized Controlled Trial
7%
Diagnosis
7%
Breast Cancer
7%
Laparoscopic Surgery
7%
Mesenchymal-Epithelial Transition
7%
Long Term Survival
7%
Magnetic Resonance Imaging
7%
Pancreas Islet Cell Tumor
7%
Operation Duration
7%
Retrospective Study
7%
Pancreatic Duct
7%
Median Survival Time
7%
Head Cancer
7%
Neoadjuvant Therapy
7%
Tumor Progression
7%
Pancreaticojejunostomy
6%
Squamous Cell Carcinoma
6%
C Reactive Protein
6%
Elderly Patient
6%
Superior Mesenteric Artery
6%
Cancer Surgery
6%
Methylation
6%
Stenosis
6%
Jejunum
6%
Positron Emission Tomography
6%
Embolization
6%
Neutrophil
6%
Colorectal Liver Metastasis
6%
Tumor Marker
6%
Indocyanine Green
6%
Adverse Event
5%
Duodenum
5%
Pancreas Carcinoma
5%
Body Mass Index
5%
Keyphrases
Hepatocellular Carcinoma
88%
Pancreatic Cancer
84%
Gastric Cancer
56%
Pancreaticoduodenectomy
49%
Tumor
49%
Overall Survival
34%
Esophageal Squamous Cell Carcinoma
31%
Resection
26%
Pancreatic Ductal Adenocarcinoma
26%
Hepatic Resection
24%
Resectable Pancreatic Cancer
23%
Multivariate Analysis
22%
Prognostic Factors
20%
Pancreatectomy
19%
Chemotherapy
18%
Peritoneal Metastasis
18%
Pancreas
18%
Poor Prognosis
17%
Japan
17%
Independent Prognostic Factor
16%
Lymph Node Metastasis
16%
Curative Resection
16%
Intraductal Papillary mucinous Neoplasm
16%
Distal Pancreatectomy
16%
Gemcitabine
14%
Computed Tomography
14%
Older Men
14%
Hepatectomy
14%
Disease-free Survival
14%
Postoperative Pancreatic Fistula
13%
Colorectal Liver Metastases
13%
Confidence Interval
13%
Liver
13%
Postoperative Complications
13%
Colorectal Cancer
12%
Hazard Ratio
12%
Adjuvant Chemotherapy
12%
Pancreatic Fistula
12%
Malignant Phenotype
12%
Recurrence-free Survival
12%
After Surgery
12%
Postoperative Day
12%
Risk Factors
11%
Odds Ratio
11%
Stomach
11%
Epithelial-to-mesenchymal Transition
10%
Esophageal Cancer
10%
Portal Vein
10%
Liver Metastasis
10%
Older Women
10%
Oncolytic Herpes Simplex Virus (oHSV)
10%
Metastasis
10%
Prognosis Prediction
9%
Tumor Suppressor
9%
Prognostic Significance
9%
Phase II Study
9%
Expression Level
9%
Array Analysis
9%
Ulcerative Colitis
9%
Long-term Survival
9%
Tumor Suppressor Gene
9%
Overexpression
9%
Prognostic Impact
8%
Splenic Vein
8%
Bevacizumab
8%
Promoter Methylation
8%
Advanced Gastric Cancer
8%
Gastric Cancer Cell Lines
8%
Triple Combination Array
8%
Peritoneal Dissemination
8%
Hepatocellular Carcinoma Cells
8%
Gemcitabine Plus Nab-paclitaxel
8%
Pathological Findings
8%
Hepatic Metastasis
8%
Gastric Tissue
8%
Peritoneal Cytology
7%
Gastric Cancer Cells
7%
Japan Pancreas Society
7%
Postoperative Outcomes
7%
Pancreatic Head
7%
Antitumor Effect
7%
Patient Survival
7%
Pancreatic Resection
7%
Postoperative Prognosis
7%
Pancreatic Surgery
7%
Univariate Analysis
7%
Conversion Surgery
7%
Neoadjuvant Therapy
7%
Median Survival Time
7%
Malignancy
7%
Cluster of Differentiation 44 (CD44)
7%
In Cancer
7%
Neoadjuvant Chemoradiotherapy (nCRT)
7%
No Significant Difference
7%
Cancer Patients
7%
Metastatic Colorectal Cancer (mCRC)
7%
Pancreatic Head Cancer
7%
Tumor Size
7%
Propensity Score Analysis
7%
Surgical Resection
6%